Lantus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: NNC0268-0965;   Drug: Insulin glargine;   Drug: Placebo (NNC0268-0965);   Drug: Placebo (insulin glargine) Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2020 Category: Research Source Type: clinical trials